PDCD1 and neoplasm: For instance, a recent report demonstrated that arachidonic acid combined with PD1/anti‐PD‐L1 blockades triggers tumour ferroptosis via the IRF1/ACSL4 axis, presenting a potential anticancer therapeutic strategy.45